Table 1

Summary of the study patient disposition

Patient enrolmentReason for discontinuationSham TTTTTT
Excluded from study
Erroneous diagnosis on review2
Discontinued treatment before first TTT42
Patient's decision11
Adverse event before first TTT*31
Received randomised treatment4448
Discontinued treatment before month 24411
Adverse event14
Patient's decision2
Unsatisfactory therapeutic effort34
Protocol deviation1
Remained on treatment at month 244038
  • * Sham transpupillary thermotherapy (TTT) (one massive submacular haemorrhage, one retinal pigment epithelium rip, one severe vision loss (>30 letters)), TTT (one severe vision loss (>30 letters)).

  • Sham TTT (one death), TTT (three deaths, one stroke).